Biophytis (EPA:ALBPS) | Finanzwire

Basculer en Français

10816	Companies
234408	Keywords
163265	Articles
125414	Press releases

Home
Companies
Biophytis

PRESS RELEASE

published on 05/29/2026 at 21:59, 2 months 11 days ago

Information on the Annual Financial Statements 2025
Biophytis SA provides an update on the progress of finalizing the 2025 annual accounts and audit procedures, facing delays. The Company is actively working with its auditors to complete the process efficiently and comply with regulatory standards

Regulatory Compliance Delay Biophytis SA Audit Procedures 2025 Annual Accounts
BRIEF

published on 05/27/2026 at 23:05, 2 months 13 days ago

Biophytis Modifies Financing Agreement with Hexagon Capital Fund

Biophytis Financing Agreement Revolving Credit Clinical Advancement Hexagon Capital
REGULATED PRESS RELEASE

published on 05/27/2026 at 23:00, 2 months 13 days ago

BIOPHYTIS CHANGES ITS FINANCING AGREEMENT WITH HEXAGON CAPITAL FUND TO ENSURE ITS €2 MILLION FACILITY IS RENEWABLE
Biophytis changes financing agreement with Hexagon Capital Fund, ensuring renewable €2 million facility, with revised terms enhancing financial flexibility and reducing interest rate

Biophytis Renewable Financial Flexibility Financing Agreement Hexagon Capital Fund
PRESS RELEASE

published on 05/27/2026 at 22:59, 2 months 13 days ago

BIOPHYTIS CHANGES ITS FINANCING AGREEMENT WITH HEXAGON CAPITAL FUND TO ENSURE ITS €2 MILLION FACILITY IS RENEWABLE
Biophytis restructures financing agreement with Hexagon Capital Fund, making €2 million facility revolving and reducing interest rate from 12% to 10%, enhancing financial flexibility and visibility

Biophytis Financing Agreement Interest Rate Reduction Hexagon Capital Fund Revolving Facility
BRIEF

published on 05/21/2026 at 07:35, 2 months 20 days ago

Biophytis Participates in First Longevity Summit

Biophytis Healthy Aging Therapeutic Approaches Géroscience Longevity Summit
REGULATED PRESS RELEASE

published on 05/21/2026 at 07:30, 2 months 20 days ago

Biophytis participates in the first Longevity Summit
Biophytis participates in the first Longevity Summit, discussing advances in geroscience and healthcare to address aging, with the participation of experts and public decision-makers

Biophytis Healthcare Aging Géroscience Longevity Summit
PRESS RELEASE

published on 05/21/2026 at 07:29, 2 months 20 days ago

Biophytis participates in the first Longevity Summit
Biophytis announces participation in the first Longevity Summit, focusing on healthy aging and transformative therapies. Key experts and partners join the discussion

Biophytis Healthy Aging Transformative Therapies Longevity Summit Scientific Discussion
BRIEF

published on 04/29/2026 at 23:05, 3 months 10 days ago

Biophytis Delays Annual Financial Statement Publication

Financial Statements Biophytis Refinancing Delay 2025 Fiscal Year
BRIEF

published on 04/29/2026 at 23:05, 3 months 10 days ago

Biophytis postpones the publication of its 2025 annual accounts

Biophytis Refinancing Regulatory Requirements Annual Accounts Publication Postponed
REGULATED PRESS RELEASE

published on 04/29/2026 at 23:00, 3 months 10 days ago

INFORMATION ON ANNUAL FINANCIAL STATEMENTS
Biophytis SA postpones the publication of its annual financial statements for the year ended December 31, 2025 due to refinancing transaction. Company aims to finalize and publish by end of May 2026

Annual Financial Statements Postponement Publication Biophytis SA Refinancing Transaction

Accesswire

Published on 08/10/2026 at 21:35, 16 minutes ago

Sekur Private Data Government Team Attending DoDIIS Worldwide Intelligence Conference
Published on 08/10/2026 at 20:30, 1 hour 21 minutes ago

Clean Air Metals and Fiore-backed Springbok Ventures Announce Upsize of Non-Brokered Private Placement
Published on 08/10/2026 at 15:30, 6 hours 21 minutes ago

Silver Spruce Resources, Inc. Announces New Chief Financial Officer
Published on 08/10/2026 at 15:25, 6 hours 26 minutes ago

Gemdale Gold Intersects 5.19m at 14.01 g/t Au within 110m at 1.18 g/t Au at the Pontio Gold Project, Finland
Published on 08/10/2026 at 14:30, 7 hours 21 minutes ago

NanoViricides Has Received Regulatory Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo To Fight the Current Largest Ever and Expanding Ebola Outbreak

View all ACCESSWIRE

EQS Group

Published on 08/10/2026 at 20:24, 1 hour 26 minutes ago

EQS-Adhoc: PNE AG updates on ongoing sales process
Published on 08/10/2026 at 19:35, 2 hours 15 minutes ago

Kontron AG: All conditions of the mandatory tender offer of Ennoconn Corporation are met – Settlement will take place shortly
Published on 08/10/2026 at 18:29, 3 hours 21 minutes ago

Fuller, Smith & Turner PLC: Director/PDMR Shareholdings
Published on 08/10/2026 at 17:50, 4 hours 1 minute ago

Disclosure according to Article 5(1)(b) of the EU Regulation No. 596/2014 and Article 2(3) of the Delegated EU Regulation No. 2016/1052 - 1st Interim Report
Published on 08/10/2026 at 17:38, 4 hours 13 minutes ago

PATRIZIA delivers strong earnings growth with EUR 42.7m EBITDA (+46.6% y-o-y) in H1 2026

Les Echos

Published on 08/10/2026 at 18:00, 3 hours 51 minutes ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 17:45, 4 hours 6 minutes ago

Weekly share buyback
Published on 08/10/2026 at 11:53, 9 hours 57 minutes ago

GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:36, 10 hours 14 minutes ago

GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Published on 08/10/2026 at 09:22, 12 hours 28 minutes ago

Number of shares and voting rights - July 2026 (In French only)

View all LES ECHOS COMFI WIRE